Borbas, Dave

Dave Borbas
Research VP,
Head of Data Management

Dave Borbas
Research VP,
Head of Data Management
Byrne, Donna

Donna Byrne
Director, Clinical Operations

Donna Byrne
Director, Clinical Operations
Chaney, Terry

Terry Chaney
Associate Director,
GMP QA Operations

Terry Chaney
Associate Director,
GMP QA Operations
Chartienitz, Brett

Brett Chartienitz
IT Operations Manager

Brett Chartienitz
IT Operations Manager
Cooper, Ken

Ken Cooper
Clinical Operations, Trial Management

Ken Cooper
Clinical Operations, Trial Management
Greenberg, Steven A.
Steven A Greenberg, M.D., M.S. is a founder of Abcuro and the Chief Scientific Advisor. Steve is a clinical neurologist at Brigham and Women’s Hospital, and Professor of Neurology at Harvard Medical School. His clinical and laboratory research focus involves translational medicine, inventing diagnostics including blood tests for dermatomyositis and inclusion body myositis, and therapeutics,

Steven A. Greenberg, MD
Chief Scientific Advisor & Co-Founder

Steven A. Greenberg, MD
Chief Scientific Advisor & Co-Founder
Gress, Mike

Mike Gress
VP, Clinical Development,
Head of Clinical Trial Management

Mike Gress
VP, Clinical Development,
Head of Clinical Trial Management
Hoffer, LaDonna

LaDonna Hoffer
Senior Director, Operations

LaDonna Hoffer
Senior Director, Operations
Hwang, Ella

Ella Hwang
Senior Director, Quality

Ella Hwang
Senior Director, Quality
Jiang, Lusi

Lusi Jiang
Senior Accountant

Lusi Jiang
Senior Accountant
LeMessurier, Hugo

Hugo LeMessurier
Director, Abcuro Pty Ltd

Hugo LeMessurier
Director, Abcuro Pty Ltd
Lurk, Kristin

Kristin Lurk
Senior Director
Program Management

Kristin Lurk
Senior Director
Program Management
Martin, Alex
Alex Martin brings over 30 years of experience building companies and closing transactions in the biopharmaceutical industry. He was most recently Chief Executive Officer of Palladio Biosciences, a clinical stage biopharmaceutical company which was acquired by Centessa Pharmaceuticals (CNTA), and previously served as Chief Executive Officer of Realm Therapeutics (RLM) which was acquired by ESSA

Alex Martin
Chief Executive Officer

Alex Martin
Chief Executive Officer
McClain, Michael

Michael McClain
Associate Director, Clinical Operations

Michael McClain
Associate Director, Clinical Operations
Motschwiller, Ricky

Richard Motschwiller
VP, Finance and Planning

Richard Motschwiller
VP, Finance and Planning
Orozco, Raquel

Raquel Orozco
Director, CMC
Manufacturing Operations

Raquel Orozco
Director, CMC
Manufacturing Operations
Reyes, Armando

Armando Reyes
Associate Clinical Director

Armando Reyes
Associate Clinical Director
Searle, Stephen

Stephen A. Searle
Senior Program Manager

Stephen A. Searle
Senior Program Manager
Shen, Yuyi

Yuyi Shen, PhD
VP, Technical Operations

Yuyi Shen, PhD
VP, Technical Operations
Soler-Ferran, Dulce, PhD

Dulce Soler-Ferran, PhD
VP, Biology

Dulce Soler-Ferran, PhD
VP, Biology
Subramanyam, Janaki
Janaki (Jana) Subramanyam is Vice President, Head of Regulatory Affairs at Abcuro. Jana is an experienced regulatory affairs professional having worked on small molecule and biologic development programs across rheumatology, nephrology, neurology, and psychiatry for more than twenty years. Her regulatory drug development expertise spans clinical, nonclinical, manufacturing, quality, post marketing advertising, and promotional activities.

Janaki M. Subramanyam
VP, Head of Regulatory Affairs

Janaki M. Subramanyam
VP, Head of Regulatory Affairs
Tubridy, Karen
Karen Tubridy is the Chief Development Officer of Abcuro. She brings more than 30 years of experience in drug development strategy and operations supporting novel and first-in-class therapeutics. Previously, Karen served as a Chief Development Officer at Verseau Therapeutics, Akebia Therapeutics, and Eleven Bio. She has had responsibility for driving global program strategies to IND,

Karen Tubridy, PharmD
Chief Development Officer

Karen Tubridy, PharmD
Chief Development Officer
Weems Gary

Garry Weems
VP, Clinical Science

Garry Weems
VP, Clinical Science
Wilkins, Jeffrey
Jeffrey Wilkins is the Chief Medical Officer of Abcuro. He is a highly experienced clinician, having advanced clinical programs from IND to regulatory approval. Jeff has deep expertise in the areas of immunology, rare diseases, and immuno-oncology. He has served in senior clinical leadership positions, including as Chief Medical Officer for over 20 years. Among

H. Jeffrey Wilkins, MD
Chief Medical Officer

H. Jeffrey Wilkins, MD
Chief Medical Officer
Jeffrey Wilkins is the Chief Medical Officer of Abcuro. He is a highly experienced clinician, having advanced clinical programs from IND to regulatory approval. Jeff has deep expertise in the areas of immunology, rare diseases, and immuno-oncology. He has served in senior clinical leadership positions, including as Chief Medical Officer for over 20 years. Among others, Jeff led clinical development programs at Avalo Therapeutics, Lycera, Ceptaris Therapeutics, Cephalon, and Ception Therapeutics. He entered the pharmaceutical industry with GlaxoSmithKline, where he rose to become Vice President of Discovery Medicine for GSK’s Center of Excellence in External Drug Discovery. Jeff received his M.D. from Temple University School of Medicine and his B.S. from Bucknell University.